Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Clinical trial NCT06222437 · WITHDRAWN

Trial details

NCT number: NCT06222437
Sponsor: Methodist Health System
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Polycystic Ovary Syndrome

Start date: 2026-02-01
Primary completion: 2026-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.